| 000 | 01555 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512020457.0 | ||
| 264 | 0 | _c19890822 | |
| 008 | 198908s 0 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | 7 |
_a10.1093/jnci/81.15.1190 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHartmann, L C | |
| 245 | 0 | 0 |
_aUse of prophylactic antibiotics for prevention of intravascular catheter-related infections in interleukin-2-treated patients. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cAug 1989 |
||
| 300 |
_a1190-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCatheterization, Central Venous _xadverse effects |
| 650 | 0 | 4 |
_aCatheters, Indwelling _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xtherapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSepsis _xetiology |
| 700 | 1 | _aUrba, W J | |
| 700 | 1 | _aSteis, R G | |
| 700 | 1 | _aSmith, J W | |
| 700 | 1 | _aVander Molen, L A | |
| 700 | 1 | _aCreekmore, S P | |
| 700 | 1 | _aSznol, M | |
| 700 | 1 | _aCasciano, M A | |
| 700 | 1 | _aEngler, N | |
| 700 | 1 | _aLongo, D L | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 81 _gno. 15 _gp. 1190-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/81.15.1190 _zAvailable from publisher's website |
| 999 |
_c2793274 _d2793274 |
||